Filter
2506
Filtered Results: 2506
Text search:
drug
trial
Featured
Recommendations
231
New Publications
500
Language
Document type
No document type
1498
Guidelines
387
Studies & Reports
376
Manuals
100
Strategic & Response Plan
52
Fact sheets
40
Training Material
22
Situation Updates
13
Infographics
8
Resource Platforms
6
Brochures
3
App
1
Countries / Regions
India
145
Global
87
South Africa
63
Western and Central Europe
55
Kenya
43
Nigeria
39
Ethiopia
38
Africa
37
Uganda
36
Eastern Europe
29
Liberia
29
Zambia
28
Malawi
27
Tanzania
27
Nepal
26
Sierra Leone
26
Russia
26
Ukraine
25
Ghana
21
Zimbabwe
20
Latin America and the Carribbean
20
Rwanda
19
Asia
18
Philippines
17
Bangladesh
17
Myanmar / Burma
16
South–East Asia Region
15
Brazil
14
East and Southern Africa
13
Namibia
13
Colombia
11
Lesotho
11
Mozambique
11
Cambodia
11
West and Central Africa
11
Germany
10
USA
9
Middle East and North Africa
9
South Sudan
9
Indonesia
9
Congo, Democratic Republic of
7
Botswana
7
Eswatini/ Swaziland
7
Tajikistan
6
Thailand
6
Syria
6
Cameroon
5
Albania
5
Senegal
5
Guinea
5
Eastern Europe and Central Asia
5
Laos
4
Burkina Faso
4
Venezuela
4
Argentina
4
Vietnam
4
Papua New Guinea
4
Sudan
4
Georgia
4
China
3
Haiti
3
Paraguay
3
Spain
3
Lebanon
3
Yemen
3
Central African Republic
3
Angola
3
Pakistan
3
North Macedonia
2
Mexico
2
Benin
2
Iran
2
Estonia
2
Kyrgyzstan
2
Morocco
2
Guinea-Bissau
2
Hungary
2
Jordan
2
Jamaica
2
United Kingdom
2
Portugal
2
Belarus
2
Southern Africa
2
Bolivia
2
Sri Lanka
2
Poland
2
Iraq
2
Turkey
1
Gambia
1
Kazakhstan
1
Singapore
1
Peru
1
Qatar
1
Bulgaria
1
Armenia
1
Lithuania
1
Ireland
1
Saudi Arabia
1
North America
1
Denmark
1
Belgium
1
France
1
Tunisia
1
Norway
1
Côte d’Ivoire / Ivory Coast
1
Greece
1
Mali
1
Bhutan
1
Somalia
1
Ecuador
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
685
Clinical Guidelines
336
Public Health
138
Women & Child Health
100
Pharmacy & Technologies
29
Key Resources
24
Capacity Building
19
Toolboxes
HIV
344
Mental Health
339
TB
298
COVID-19
162
NTDs
116
AMR
89
NCDs
77
Pharmacy
72
Ebola
57
Rapid Response
34
Caregiver
30
Refugee
28
Planetary Health
25
Disability
24
Global Health Education
16
Conflict
14
Health Financing Toolbox
12
Polio
9
Social Ethics
7
Specific Hazards
5
Natural Hazards
5
Cholera
5
Zika
3
Health Financing
1
Revised working paper following AVAREF meeting February 2019.
WHO has published a roadmap aiming to coordinate partners’ actions and contributions to the licensing and roll-out of Merck’s Ebola vaccine (VSV-ZEBOV) in African countries. The vaccine was developed during the West Africa Ebola epi...
Of the 50 antibiotics in the pipeline, 32 target WHO priority pathogens but the majority have only limited benefits when compared to existing antibiotics. Two of these are active against the multi-drug resistant Gram-negative bacteria, which are spreading rapidly and require urgent solutions.
Gr...
The Pharmacovigilance team in WHO aims to assure the safety of medicines and vaccines by ensuring reliable and timely exchange of information on safety issues, promoting pharmacovigilance activities throughout the Organization and encouraging participation in the WHO Programme for International Drug...
Arsenical monotherapies were previously very successful for treating human African trypanosomiasis (HAT).
Melarsoprol resistance emerged as early as the 1970s and was widespread by the late 1990s.
Melarsoprol resistance represents the only example of widespread drug resistance in HAT patients wher...
Yaws is targeted for eradication by 2030, using a strategy based on mass drug administration (MDA) with azithromycin. New diagnostics are needed to aid eradication. Serology is currently the mainstay for yaws diagnosis; however, inaccuracies associated with current serological tests makes it difficu...
In 2014, an estimated 40 million women of reproductive age were infected with Schistosoma haematobium, S. japonicum and/or S. mansoni. In both 2003 and 2006, the World Health Organization (WHO) recommended that all schistosome-infected pregnant and breastfeeding women be offered treatment, with praz...
May 9, 2022.Since the onset of the COVID-19 pandemic, a large number of clinical trials have been planned and developed to assess the effectiveness and safety of various interventions that could prevent hospitalizations and progression to severe disease in people infected with SARS-CoV-2. Currently,...
This special issue on Newborn Health in Global Health Action is being launched to share the experience of how to scale up a cost-effective package of newborn care that involves families, community health workers and health facilities. The results of this community randomized trial, the Uganda Newbor...
The 2014–2015 Ebola epidemic in western Africa was the longest and most deadly Ebola epidemic in history, resulting in 28,616 cases and 11,310 deaths in Guinea, Liberia, and Sierra Leone. The Ebola virus has been known since 1976, when two separate outbreaks were identified in the Democratic Repub...
Fever Diagnostic Technology Landscape
recommended
1st edition.
Unitaid’s report describes a slate of new devices that can more efficiently identify dangerously ill children so that they can be treated immediately. These tools make it easier to recognize danger signs, and support integrated approaches to reducing childhood deaths from the three ...
The main objective of these guidelines is to provide guidance on up-to-date, uniform, evidence-informed practices for suspecting, diagnosing and managing various forms of extra-pulmonary tuberculosis (EPTB) at all levels of healthcare delivery. They can then contribute to the National Programme to i...
This document updates the earlier version published in April 2020. In recent weeks, information on the potential use of chloroquine or hydroxychloroquine for the treatment of people with COVID-19 has been disseminated in academic journals and public media. Although there are now ongoing clinical tri...
Co-trimoxazole is a fixed-dose combination of two antimicrobial drugs (sulfamethoxazole and trimethoprim) that covers a variety of bacterial, fungal and protozoan infections. Co-trimoxazole preventive therapy is a feasible, well tolerated and inexpensive intervention for people living with HIV to re...
As of 31 October 2020 This is the tenth edition of this summary of rapid systematic reviews, which includes the results of a rapid systematic review of currently available literature. More than 200 therapeutic options or their combinations are being investigated in more than 1,700 clinical trials. I...
WHO Living guideline: Drugs to prevent COVID-19
recommended
Interim guidance 2 march 2021
Current use of drugs to prevent COVID-19 is variable, reflecting large-scale uncertainty. Numerous randomized trials of many different drugs are underway to inform practice. This first version of the Drugs to prevent COVID-19: A WHO living guideline contains new inform...
A living WHO guideline on drugs for covid-19
recommended
BMJ 2020; 370 doi: https://doi.org/10.1136/bmj.m3379
Rapid Recommendation and visual graph. This is the fifth version (update 4) of the living guideline (BMJ 2020;370:m3379). When citing this article, please consider adding the update number and date of access for clarity. The publication of the RE...
This manual summarizes key issues related to the safety of NTD medicines and their administration, with a focus on essential medicines used in mass drug administration (MDA), also called preventive chemotherapy. It can be used as a standalone reference manual, but is intended to be used in conjuncti...
The Updated guidelines on Management of tuberculosis in children and adolescents include new recommendations that cover diagnostic approaches for TB, shorter treatment for children with non-severe drug-susceptible TB, a new option for the treatment of TB meningitis, the use of bedaquiline and delama...
To support its R&D activities on Chagas disease, DNDi launched the Chagas Clinical Research Platform (CCRP). The platform brings together partners, experts, and stakeholders to provide support for evaluation and development of new treatments for Chagas disease. The patient-centred platform aims to f...
This chapter discusses the antibacterial treatment of leprosy infections. Antibiotic treatment is
a key component of leprosy treatment, as it is vital to prevent the progression of the infection.
Treatment with rifampin and other antibiotics is highly effective and cures 98% of patients with
the ...
